| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | PLXNB1 |
| Uniprot No | O43157 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 20-535aa |
| 氨基酸序列 | LQPLPPTAFTPNGTYLQHLARDPTSGTLYLGATNFLFQLSPGLQLEATVSTGPVLDSRDCLPPVMPDECPQAQPTNNPNQLLLVSPGALVVCGSVHQGVCEQRRLGQLEQLLLRPERPGDTQYVAANDPAVSTVGLVAQGLAGEPLLFVGRGYTSRGVGGGIPPITTRALWPPDPQAAFSYEETAKLAVGRLSEYSHHFVSAFARGASAYFLFLRRDLQAQSRAFRAYVSRVCLRDQHYYSYVELPLACEGGRYGLIQAAAVATSREVAHGEVLFAAFSSAAPPTVGRPPSAAAGASGASALCAFPLDEVDRLANRTRDACYTREGRAEDGTEVAYIEYDVNSDCAQLPVDTLDAYPCGSDHTPSPMASRVPLEATPILEWPGIQLTAVAVTMEDGHTIAFLGDSQGQLHRVYLGPGSDGHPYSTQSIQQGSAVSRDLTFDGTFEHLYVMTQSTLLKVPVASCAQHLDCASCLAHRDPYCGWCVLLGRCSRRSECSRGQGPEQWLWSFQPELGCLQ |
| 预测分子量 | 83.2 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3篇涉及PLXNB1(Plexin B1)重组蛋白研究的参考文献示例(注：部分内容基于领域内典型研究方向整合，可能需要核实具体文献)：
1. **"Structural basis of semaphorin-plexin signaling"**
- **作者**: Janssen, B.J., et al.
- **摘要**: 本研究通过表达重组PLXNB1胞外域蛋白，解析其与Semaphorin 4D的复合物晶体结构，揭示了二者相互作用的分子机制，并阐明下游RhoA信号激活的结构基础。
2. **"Plexin-B1 regulates Rho through PDZ-RhoGEF in receptor dimerization-dependent manner"**
- **作者**: Swiercz, J.M., et al.
- **摘要**: 利用重组PLXNB1蛋白进行体外结合实验，证明其通过PDZ-RhoGEF激活Rho信号通路，并发现受体二聚化是触发下游信号传导的关键步骤。
3. **"Recombinant Plexin-B1 ectodomain inhibits tumor angiogenesis in vitro and in vivo"**
- **作者**: Valdembri, D., et al.
- **摘要**: 研究通过哺乳动物细胞表达系统制备重组PLXNB1胞外区蛋白，发现其可竞争性阻断Semaphorin 4D介导的内皮细胞迁移和血管生成，提示其作为抗肿瘤治疗的潜在工具。
4. **"Plexin-B1 mutations disrupt MET signaling and correlate with cancer progression"**
- **作者**: Rody, A., et al.
- **摘要**: 通过重组PLXNB1突变体蛋白的功能分析，揭示了其在MET受体交叉对话中的调控作用，并发现特定突变体与乳腺癌转移风险增加相关。
(注：以上文献标题及内容为领域典型研究方向示例，实际引用时建议通过PubMed或Google Scholar以“PLXNB1 recombinant protein”为关键词检索最新或具体研究。)
PLXNB1 (Plexin B1) is a transmembrane receptor protein belonging to the plexin family, which plays a critical role in mediating cellular signaling pathways involved in cell migration, axon guidance, and tissue morphogenesis. It was initially identified as a high-affinity receptor for semaphorins, particularly Sema4D (SEMA4D), a class of membrane-bound or secreted proteins that regulate immune responses, angiogenesis, and neural development. Structurally, PLXNB1 contains a large extracellular domain with sema, cysteine-rich, and immunoglobulin-like motifs for ligand binding, a single-pass transmembrane region, and a cytoplasmic domain that interacts with downstream signaling molecules, including Rho GTPases. This interaction facilitates cytoskeletal reorganization and directional cell movement.
Research has highlighted PLXNB1's involvement in diverse physiological and pathological processes. In cancer biology, PLXNB1 overexpression has been linked to tumor progression, metastasis, and angiogenesis, as it promotes invasive cell behavior and endothelial cell activation. In the nervous system, it contributes to axon guidance and neural circuit formation by modulating growth cone dynamics. Additionally, PLXNB1 interacts with other receptors, such as MET (hepatocyte growth factor receptor), amplifying oncogenic signaling pathways like MAPK/ERK and PI3K/AKT, which are often dysregulated in malignancies.
Recombinant PLXNB1 protein, produced through engineered expression systems (e.g., mammalian or insect cells), retains functional domains for ligand binding and signaling studies. It is widely used in *in vitro* assays to investigate receptor-ligand interactions, downstream signaling cascades, and therapeutic targeting. Recent studies also explore its potential as a biomarker or therapeutic target in cancers and neurological disorders. Despite progress, the dual roles of PLXNB1 in pro- and anti-tumorigenic contexts, depending on cellular microenvironments, warrant further mechanistic exploration to harness its clinical potential effectively.
×
